Using CTCA to guide management in suspected ACS without MI is not warranted.
X post ↗What happened
Early outpatient CT coronary angiography fails to reduce MI or CV death versus standard care.
Using CTCA to guide management in suspected ACS without MI is not warranted.
X post ↗Notes that the 3,170 patients had MI ruled out but intermediate hs-troponin (≥5 ng/L to <99th percentile), and asks what prognostic role CTCA has in acute chest pain.
X post ↗Adult Congenital Heart Disease
These findings demonstrate why high-quality clinical trials are required to answer important questions about patient care. Robust and representative evidence ensures that the right people receive the right tests at the right time, supporting the best possible outcomes for heart patients while making effective use of health care resources.
TARGET-CTCAOur findings provide strong evidence that patients who have had a heart attack excluded do not benefit from early outpatient CTCA scans. Once we are confident that they haven't had a heart attack, we can reassure these patients that their future risk is low and send them home.
TARGET-CTCAGeneral · Cedars-Sinai Medical Center
@gcfmd @kewatson @NEJM @boback @texhern @HeartBobH @HeartDocSadiya @ericpetersonMD As in RAPID-CTCA improved diagnostic eficiency did not translate into improved patient outcomes in TARGET-CTCA.
TARGET-CTCA🖋️In patients with suspected ACS without MI, routine CT coronary angiography did NOT RESULT in a lower incidence of MI or ☠️from a cardiac cause than standard care. 🫀Full TARGET-CTCA trial results: nej.md/4wH7Yk7
t.coTARGET-CTCAOpen questions from this trial that would benefit from expert input.
Answers are grounded in this paper and cite their sources.
Why the trial, tables, limitations, PICO, abstract, media & sources
Patients whose acute chest pain proves not to be myocardial infarction still carry meaningful longer-term coronary risk. TARGET-CTCA asked whether early outpatient CT coronary angiography after MI has been ruled out prevents subsequent infarction or cardiovascular death.
Does outpatient CT coronary angiography-guided care reduce the composite of myocardial infarction or death from a cardiac cause in patients with suspected acute coronary syndrome in whom myocardial infarction has been ruled out and who have intermediate risk?
| Outcome | CTCA-guided | Standard care |
|---|---|---|
| MI or death from a cardiac cause Adjusted HR 0.95 (95% CI 0.73-1.23; P=0.71) · no benefit; treatment separation was good (CTCA in 92.1% vs 2.2%) | CTCA-guided 112/1,587 (7.1%) | Standard care 116/1,583 (7.3%) |
Does outpatient CT coronary angiography-guided care reduce the composite of myocardial infarction or death from a cardiac cause in patients with suspected acute coronary syndrome in whom myocardial infarction has been ruled out and who have intermediate risk?
Experts read TARGET-CTCA as a clear null result: once a heart attack is ruled out, routine coronary CT scanning does not improve outcomes and is not needed.
The few clinicians who commented agree that early outpatient coronary CT after a heart attack is ruled out did not prevent later heart attacks or cardiac deaths. They read it as support for reassuring these patients and sending them home rather than scanning them by routine. The open question is whether coronary CT has any prognostic role in acute chest pain, since better diagnosis has not led to better outcomes.
Clinicians agree that routine CTCA after myocardial infarction has been ruled out gives no outcome benefit and should not be used by routine to guide management.
What they’re arguing about
supportiveneutralcautiouscritical
Counts are expert takes we classified by axis. Tap a row to see the takes behind its count.
One clinician's thread asks what value and prognostic role CTCA still has in acute chest pain, and the posts do not answer it. Another points out that better diagnostic efficiency has now failed twice to improve patient outcomes.
Routine outpatient CT coronary angiography-guided management did not reduce the incidence of subsequent myocardial infarction or cardiac death compared to standard care in patients with suspected ACS and intermediate risk after MI rule-out.
BackgroundMany patients with suspected acute coronary syndrome in whom myocardial infarction has been ruled out in the emergency department remain at risk for cardiovascular events. Whether further investigation reduces this risk is unknown. MethodsIn a multicenter, randomized, controlled trial, patients who presented to an emergency department in 14 hospitals across the United Kingdom were enrolled if myocardial infarction had been ruled out and high-sensitivity cardiac troponin testing indicated an intermediate risk of a cardiovascular event (maximum high-sensitivity cardiac troponin I or T concentration, >5 ng per liter). Participants were randomly assigned in a 1:1 ratio to receive either outpatient computed tomographic (CT) coronary angiography–guided care or standard care. The primary outcome was a composite of myocardial infarction or death from a cardiac cause. ResultsFrom September 18, 2019, to May 11, 2023, a total of 3170 participants (median age, 61 years; female sex, 30.2%) were assigned to undergo CT coronary angiography (1587 participants) or receive standard care (1583 participants). At 90 days after randomization, CT coronary angiography had been performed in 1462 participants (92.1%) in the CT coronary angiography group and in 35 participants (2.2%) in the standard-care group. Overall, 7 participants (0.4%) had a CT coronary angiography–related adverse event. After a median of 3.0 years, at which point the number of primary-outcome events in the standard-care group exceeded the prespecified minimum of 97, a primary-outcome event had occurred in 112 participants (7.1%) in the CT coronary angiography group and in 116 (7.3%) in the standard-care group (adjusted hazard ratio, 0.95; 95% confidence interval, 0.73 to 1.23; P=0.71). ConclusionsIn patients with suspected acute coronary syndrome in whom myocardial infarction had been ruled out, routine CT coronary angiography–guided management did not result in a lower incidence of subsequent myocardial infarction or death from a cardiac cause than standard care. (Funded by the British Heart Foundation; TARGET-CTCA ClinicalTrials.gov number, NCT03952351.)
Lee et al. (2026) conducted an RCT in Suspected acute coronary syndrome (n=3,170). CT coronary angiography-guided care vs. Standard care was evaluated on Composite of myocardial infarction or death from a cardiac cause (HR 0.95, 95% CI 0.73 to 1.23, p=0.71). Routine CT coronary angiography-guided management did not reduce the incidence of myocardial infarction or cardiac death compared to standard care.
Synapse has enriched 10 related papers. Consider them for comparative context: